Medipharm Labs Corp (LABS) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.022x

Based on the latest financial reports, Medipharm Labs Corp (LABS) has a cash flow conversion efficiency ratio of -0.022x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-778.00K ≈ $-562.79K USD) by net assets (CA$35.10 Million ≈ $25.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medipharm Labs Corp (LABS) total market value for the company's overall valuation and market capitalisation.

Medipharm Labs Corp - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Medipharm Labs Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medipharm Labs Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medipharm Labs Corp ranked by their cash flow conversion efficiency. Explore LABS cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Eastparc Hotel Tbk PT JK:EAST	0.017x
ALUMEXX N.V. NAM. EO-10 F:NE8F	N/A
Rimfire Pacific Mining Ltd AU:RIM	-0.126x
MESB Bhd KLSE:7234	0.049x
GeneMatrix Inc KQ:109820	0.027x
VRX Silica Ltd AU:VRX	-0.090x
AJ Advance Technology Public Company Limited BK:AJA	-0.019x
BMS Celik Hasir Sanayi ve Ticaret AS IS:BMSCH	-0.070x

Annual Cash Flow Conversion Efficiency for Medipharm Labs Corp (2016–2025)

The table below shows the annual cash flow conversion efficiency of Medipharm Labs Corp from 2016 to 2025. View current stock price of Medipharm Labs Corp for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$35.81 Million ≈ $25.91 Million	CA$-5.50 Million ≈ $-3.98 Million	-0.154x	-36.54%
2024-12-31	CA$43.18 Million ≈ $31.24 Million	CA$-4.86 Million ≈ $-3.52 Million	-0.113x	+51.65%
2023-12-31	CA$53.01 Million ≈ $38.34 Million	CA$-12.34 Million ≈ $-8.93 Million	-0.233x	+18.87%
2022-12-31	CA$56.01 Million ≈ $40.51 Million	CA$-16.07 Million ≈ $-11.62 Million	-0.287x	-80.55%
2021-12-31	CA$83.15 Million ≈ $60.15 Million	CA$-13.21 Million ≈ $-9.56 Million	-0.159x	+67.01%
2020-12-31	CA$78.41 Million ≈ $56.72 Million	CA$-37.77 Million ≈ $-27.32 Million	-0.482x	-150.20%
2019-12-31	CA$131.23 Million ≈ $94.93 Million	CA$-25.27 Million ≈ $-18.28 Million	-0.193x	+51.76%
2018-12-31	CA$27.84 Million ≈ $20.14 Million	CA$-11.11 Million ≈ $-8.04 Million	-0.399x	-410.70%
2017-12-31	CA$-2.12 Million ≈ $-1.54 Million	CA$166.00K ≈ $120.08K	-0.078x	+69.21%
2016-12-31	CA$215.46K ≈ $155.86K	CA$-54.69K ≈ $-39.56K	-0.254x	--

About Medipharm Labs Corp

TO:LABS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$21.51 Million

CA$29.74 Million CAD

Market Cap Rank

#24972 Global

#969 in Canada

Share Price

CA$0.07

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.09

All Time High

CA$7.17